Megalencephaly
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS) (NCT05563831) | Institut National de la Santé Et de la Recherche Médicale, France | 2023-02-21 |
Track Megalencephaly automatically
Every clearance here is in the API, with alerts when new ones post.